When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
AIMT - FDA Ad Com Friday for Aimmune's AR101 for peanut allergy; shares up 8%
Aimmune Therapeutics Inc.
The FDA's Allergenic Products Advisory Committee will meet on Friday, September 13, to review and discuss Aimmune Therapeutics' (NASDAQ:AIMT) marketing application for AR101, branded as Palforzia, to reduce the incidence and severity of allergic reactions to peanut in young people aged 4 - 17 who have a confirmed diagnosis of peanut allergy.
More news on: Aimmune Therapeutics, Inc., Healthcare stocks news, Stocks on the move,